{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:04:50Z","timestamp":1762643090374,"version":"3.37.3"},"reference-count":24,"publisher":"American Society of Hematology","issue":"20","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,22]]},"DOI":"10.1182\/bloodadvances.2024013670","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T16:06:25Z","timestamp":1724947585000},"page":"5426-5429","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Biomarker-derived fast-and-frugal decision tree for preemption of\u00a0veno-occlusive disease\/sinusoidal obstructive syndrome"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-2775","authenticated-orcid":false,"given":"Sophie","family":"Paczesny","sequence":"first","affiliation":[{"name":"1Departments of Microbiology and Immunology and Pediatrics, Medical University of South Carolina, Charleston, SC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2349-5707","authenticated-orcid":false,"given":"Iztok","family":"Hozo","sequence":"additional","affiliation":[{"name":"2Department of Mathematics and Actuarial Science, Indiana University Northwest, Gary, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Djulbegovic","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Medical University of South Carolina, Charleston, SC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"issue":"4","key":"2024102113052253600_bib1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41409-020-01135-3","article-title":"Underdiagnosed veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party","volume":"56","author":"Bazarbachi","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2024102113052253600_bib2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.bbmt.2017.07.021","article-title":"Consensus report by pediatric acute lung injury and sepsis investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: supportive care guidelines for management of veno-occlusive disease in children and adolescents, part 1: focus on investigations, prophylaxis, and specific treatment","volume":"23","author":"Bajwa","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2024102113052253600_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/oli.2006.16.105","article-title":"Defibrotide, a polydisperse mixture of single-stranded phosphodiester oligonucleotides with lifesaving activity in severe hepatic veno-occlusive disease: clinical outcomes and potential mechanisms of action","volume":"16","author":"Kornblum","year":"2006","journal-title":"Oligonucleotides"},{"issue":"13","key":"2024102113052253600_bib4","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2024102113052253600_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjh.15267","article-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"181","author":"Kernan","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"2024102113052253600_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14740338.2012.749855","article-title":"Drug safety evaluation of defibrotide","volume":"12","author":"Richardson","year":"2013","journal-title":"Expert Opin Drug Saf"},{"issue":"9823","key":"2024102113052253600_bib7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"2024102113052253600_bib8","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S2352-3026(23)00011-X","article-title":"Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial","volume":"10","author":"Grupp","year":"2023","journal-title":"Lancet Haematol"},{"issue":"10","key":"2024102113052253600_bib9","doi-asserted-by":"crossref","first-page":"e168221","DOI":"10.1172\/jci.insight.168221","article-title":"Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"8","author":"Han","year":"2023","journal-title":"JCI Insight"},{"issue":"8","key":"2024102113052253600_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/jep.13915","article-title":"Generalised decision curve analysis for explicit comparison of treatment effects","volume":"29","author":"Hozo","year":"2023","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"3","key":"2024102113052253600_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/jep.13953","article-title":"Improving methods of clinical practice guidelines: from guidelines to pathways to fast-and-frugal trees and decision analysis to develop individualised patient care","volume":"30","author":"Djulbegovic","year":"2024","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"5","key":"2024102113052253600_bib12","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/jep.12895","article-title":"Transforming clinical practice guidelines and clinical pathways into fast-and-frugal decision trees to improve clinical care strategies","volume":"24","author":"Djulbegovic","year":"2018","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"1","key":"2024102113052253600_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jep.13780","article-title":"Evaluation of a fast-and-frugal clinical decision algorithm ('pathways') on clinical outcomes in hospitalised patients with COVID-19 treated with anticoagulants","volume":"29","author":"Djulbegovic","year":"2023","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"1","key":"2024102113052253600_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/jep.12490","article-title":"Towards theory integration: threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theory","volume":"23","author":"Hozo","year":"2017","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"2","key":"2024102113052253600_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1037\/a0022684","article-title":"A\u00a0signal-detection analysis of fast-and-frugal trees","volume":"118","author":"Luan","year":"2011","journal-title":"Psychol Rev"},{"edition":"1st ed.","year":"2021","author":"Katsikopoulos","key":"2024102113052253600_bib16"},{"issue":"2","key":"2024102113052253600_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jep.13091","article-title":"The threshold model revisited","volume":"25","author":"Djulbegovic","year":"2019","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"10","key":"2024102113052253600_bib18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","article-title":"Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"21","author":"Akil","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2024102113052253600_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbmt.2017.03.022","article-title":"Cost-effectiveness of defibrotide in the prophylaxis of veno-occlusive disease after pediatric allogeneic stem cell transplantation","volume":"23","author":"Pichler","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2024102113052253600_bib20","doi-asserted-by":"crossref","first-page":"383.e1","DOI":"10.1016\/j.jtct.2023.03.014","article-title":"Incidence of sinusoidal obstruction syndrome\/veno-occlusive disease and treatment with defibrotide in allogeneic transplantation: a multicenter Australasian registry study","volume":"29","author":"Coutsouvelis","year":"2023","journal-title":"Transplant Cell Ther"},{"year":"23  2023","author":"Ravaioli","key":"2024102113052253600_bib21"},{"issue":"3","key":"2024102113052253600_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment","volume":"22","author":"Dalle","year":"2016","journal-title":"Biol Blood Marrow Tranplant"},{"issue":"4","key":"2024102113052253600_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation","volume":"168","author":"Carreras","year":"2015","journal-title":"Br J Haematol"},{"issue":"26","key":"2024102113052253600_bib24","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1182\/blood-2014-03-551630","article-title":"How I treat sinusoidal obstruction syndrome","volume":"123","author":"Chao","year":"2014","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/20\/5426\/2247358\/blooda_adv-2024-013670-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/20\/5426\/2247358\/blooda_adv-2024-013670-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T13:05:38Z","timestamp":1729515938000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/20\/5426\/517614\/Biomarker-derived-fast-and-frugal-decision-tree"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":24,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013670","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published":{"date-parts":[[2024,10,15]]}}}